680 related articles for article (PubMed ID: 31023220)
41. Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
Kou CJ; Kandpal RP
Biomed Res Int; 2018; 2018():7390104. PubMed ID: 29682554
[TBL] [Abstract][Full Text] [Related]
42. Eph receptors and ephrins in cancer: bidirectional signalling and beyond.
Pasquale EB
Nat Rev Cancer; 2010 Mar; 10(3):165-80. PubMed ID: 20179713
[TBL] [Abstract][Full Text] [Related]
43. A mathematical model for eph/ephrin-directed segregation of intermingled cells.
Aharon R; Janes PW; Burgess AW; Hamza K; Klebaner F; Lackmann M
PLoS One; 2014; 9(12):e111803. PubMed ID: 25436892
[TBL] [Abstract][Full Text] [Related]
44. Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function.
Atapattu L; Saha N; Llerena C; Vail ME; Scott AM; Nikolov DB; Lackmann M; Janes PW
J Cell Sci; 2012 Dec; 125(Pt 24):6084-93. PubMed ID: 23108669
[TBL] [Abstract][Full Text] [Related]
45. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
46. Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.
Gucciardo E; Sugiyama N; Lehti K
Cell Mol Life Sci; 2014 Oct; 71(19):3685-710. PubMed ID: 24794629
[TBL] [Abstract][Full Text] [Related]
47. Eph/ephrin reverse signalling induces axonal retraction through RhoA/ROCK pathway.
Takeuchi S; Katoh H; Negishi M
J Biochem; 2015 Sep; 158(3):245-52. PubMed ID: 25922200
[TBL] [Abstract][Full Text] [Related]
48. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
Noberini R; De SK; Zhang Z; Wu B; Raveendra-Panickar D; Chen V; Vazquez J; Qin H; Song J; Cosford ND; Pellecchia M; Pasquale EB
Chem Biol Drug Des; 2011 Oct; 78(4):667-78. PubMed ID: 21791013
[TBL] [Abstract][Full Text] [Related]
49. Eph and ephrin interactions in bone.
Matsuo K
Adv Exp Med Biol; 2010; 658():95-103. PubMed ID: 19950019
[TBL] [Abstract][Full Text] [Related]
50. Eph/Ephrin signaling in injury and inflammation.
Coulthard MG; Morgan M; Woodruff TM; Arumugam TV; Taylor SM; Carpenter TC; Lackmann M; Boyd AW
Am J Pathol; 2012 Nov; 181(5):1493-503. PubMed ID: 23021982
[TBL] [Abstract][Full Text] [Related]
51. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
52. Ephrin expression and function in cancer.
McCarron JK; Stringer BW; Day BW; Boyd AW
Future Oncol; 2010 Jan; 6(1):165-76. PubMed ID: 20021216
[TBL] [Abstract][Full Text] [Related]
53. Eph receptor tyrosine kinases in cancer stem cells.
Chen J; Song W; Amato K
Cytokine Growth Factor Rev; 2015 Feb; 26(1):1-6. PubMed ID: 24933439
[TBL] [Abstract][Full Text] [Related]
54. Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.
Darling TK; Lamb TJ
Front Immunol; 2019; 10():1473. PubMed ID: 31333644
[TBL] [Abstract][Full Text] [Related]
55. Eph-ephrin signaling modulated by polymerization and condensation of receptors.
Ojosnegros S; Cutrale F; Rodríguez D; Otterstrom JJ; Chiu CL; Hortigüela V; Tarantino C; Seriola A; Mieruszynski S; Martínez E; Lakadamyali M; Raya A; Fraser SE
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13188-13193. PubMed ID: 29192024
[TBL] [Abstract][Full Text] [Related]
56. Eph family functions from an evolutionary perspective.
Drescher U
Curr Opin Genet Dev; 2002 Aug; 12(4):397-402. PubMed ID: 12100883
[TBL] [Abstract][Full Text] [Related]
57. Regulation and misregulation of Eph/ephrin expression.
Arvanitis DN; Davy A
Cell Adh Migr; 2012; 6(2):131-7. PubMed ID: 22568953
[TBL] [Abstract][Full Text] [Related]
58. Structural and Functional Insights into the Transmembrane Domain Association of Eph Receptors.
Sahoo AR; Buck M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445298
[TBL] [Abstract][Full Text] [Related]
59. Bidirectional modulation of synaptic functions by Eph/ephrin signaling.
Klein R
Nat Neurosci; 2009 Jan; 12(1):15-20. PubMed ID: 19029886
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
